Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Advancements in Case Studies

Low Phospholipid Associated Cholelithiasis (LPAC) Syndrome: A Case Report

Submission:October 03, 2024;Published: November 11, 2024

DOI: 10.31031/AICS.2024.04.000587

ISSN 2639-0531
Volume4 Issue3

Abstract

Low phospholipid associated cholelithiasis (LPAC) syndrome is a rare disease described for the first time in 2011 by Rosmorduc et al. [1] . It is one of the syndromes associated with ABCB4 gene mutation, which codes for the MDR3 protein, a biliary carrier. Characteristics of this syndrome include intrahepatic lithiasis, symptomatic cholesterol stones with early onset (<40 years), recurrent symptoms post cholecystectomy and symptom resolution with ursodeoxycholic acid (UDCA). We present a case of middle-aged female patient who presented with epigastric pain one year after cholecystectomy. The diagnosis of LPAC syndrome was suspected on clinical and radiological presentation. The patient was treated with ursodeoxycholic acid with a good outcome.

Keywords:LPAC syndrome; Low phospholipid associated cholelithiasis; Intrahepatic lithiasis; ABCB4/ MDR3 mutation

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 260 Madison Ave, 8th Floor
  •     New York, NY 10016, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com